Microalbumin Test Market Research Report - Global Forecast till 2027

Microalbumin Test Market Research Report: By Product (Analyzer, Reagent Kit, Control Kit, Micro-Cuvettes, Test Strips), Indication (Kidney Disease, Diabetes, High Blood Pressure), End User (Hospitals, Diagnostics Laboratories) – Global Forecast till 2027

ID: MRFR/LS/3865-HCR | | Region: Global | 206 pages

Market Synopsis of the Microalbumin Test Market


Microalbumin test is a type of urine test that is used to diagnose kidney diseases. It is also used to evaluate the risk of kidney diseases among the patients diagnosed with diabetes or diabetic retinopathy. Microalbumin test, urine protein tests, and creatinine clearance tests are most widely used urine tests in hospitals and diagnostic centers. Various instruments and devices are used during the microalbumin tests such as urine analyzers, reagent kit, control kit, micro-cuvettes, and test strips.


Technology advancement in the medical device industry, increasing prevalence of diabetes, and rising demand for diagnostic and treatment services for chronic diseases is fuelling the growth of the market across the globe. Additionally, increasing geriatric population with diabetes is further accelerating the market growth. However, there are various factors restraining the market such as high cost of diagnostic medical devices and accuracy of the test.


The Microalbumin Test Market is expected to grow at a CAGR of 5.1% during the forecast period.


Key Players in the Global Microalbumin Test Market   


Some of the key players in this Microalbumin Test Market are Beckman Coulter (U.S.), Siemens (Germany), Nova Biomedical (U.S.), Roche (Switzerland), Abbott (U.S.), URIT Medical (China), ARKRAY (Japan), OPTI Medical (U.S.), ACON Laboratories (US), Sysmex (Japan), 77 Elektronika (Hungary), and Randox Laboratories (U.K)
FIGURE 1: Microalbumin Test Market by Region, 2016 (%) Microalbumin Test Market


Source: World Health Organization, Centers for Disease Control and Prevention, European Society of Clinical Microbiology and Infectious Diseases, U.S. National Library of Medicine, National Organization for Rare Disorders, The American Autoimmune Related Diseases Association, The International Society for Human and Animal Mycology, Expert Interview Market Research Future Analysis, Annual report, White paper, Company Presentation.


Intended Audience



  • Medical Device Manufacturers

  • Medical Device Suppliers

  • Medical Research Laboratories

  • Research and Development (R&D) Companies

  • Market Research and Consulting Service Providers

  • Potential Investors


Segments


The microalbumin test market is segmented on the basis of product, indication, and end user.


On the basis of the product, the market is segmented into the analyzer, reagent kit, control kit, micro-cuvettes, test strips, and others.


On the basis of the indication, the market is segmented into kidney disease, diabetes, high blood pressure, and others.


On the basis of the end user, the market is segmented into hospitals, diagnostics laboratories, research laboratories, and others.


Research Methodology Microalbumin Test Market 2018


Regional Analysis of the Global Microalbumin Test Market                 


The microalbumin test market is expected to have a steady but positive growth, with the Americas holding the largest share in the market. The growth of the market in America is attributed to the extensive use of medical devices for the diagnosis of chronic diseases such as kidney diseases, cardiovascular diseases, and diabetes. Additionally, the presence of key players manufacturing diagnostic devices, instruments, and consumables is fuelling the growth of the market in the Americas. In North America, the U.S. holds the largest market share followed by Canada. The growth of the market in the U.S. is attributed to the increasing demand for technologically advanced devices, and flourishing growth of medical device industry. Moreover, diagnostic services have become an integral part of chronic disease management in the healthcare sector in the U.S. and Canada.


Europe holds the second largest market share in microalbumin test market whose growth is attributed to extensive research and development activities in the field of cardiology and urology. Additionally, increasing number of patients with cardiovascular diseases and diabetes are also influencing the market growth. Germany holds the largest market share in the European region followed by France and the U.K. In Germany, key players such as Siemens are engaged in strategic approaches such as product launch, acquisition, and partnership to achieve growth in the market. Tapping new market is another important strategy of key players in the microalbumin test market.


In Asia Pacific, the market is exhibiting high exponential growth due to increasing number of specialty care services in healthcare and growth of medical device sector. There is an increasing demand for automated devices such as analyzers and imaging devices which further fuel the market growth. India and China are the largest contributors to the market growth. Rising geriatric population with cardiovascular disease and diabetes and availability of skilled healthcare professionals such as urologists is also driving the market.


In the Middle East & Africa, the market is driven by the availability of tertiary care centers such as diabetes clinics, cardiology centers, and emergency care centers. Additionally, increase in demand for new diagnostics and imaging devices fuel the market growth in the United Arab Emirates (UAE), and Saudi Arabia. In Africa, there is an increasing demand for primary healthcare as the prevalence of non-communicable diseases is increasing along with the communicable diseases. The urge of improving the healthcare system and rising government support further induce Microalbumin Test Market growth in this region.



Frequently Asked Questions (FAQ) :


Global microalbumin test market is expected to showcase growth at 5.1% CAGR from 2017 to 2023.

Early detection of kidney disease at a preventive stage is the primary driver of the global microalbumin test market.

High costs of diagnostic devices and concerns regarding test accuracy are factors restraining the global microalbumin test market growth.

The Americas is expected to lead in the global microalbumin test market till 2023.

Abbott, ARKRAY, Siemens, URIT Medical, 77 Elektronika, Sysmex, Randox Laboratories, Nova Biomedical, OPTI Medical, Beckman Coulter, Roche, and ACON Laboratories are prominent players of the global microalbumin test market.

Table of Content

1. Report Prologue

2. Market Introduction

2.1 Definition

2.2 Scope of the Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary research

3.4 Market Size Estimation

4. Market Dynamics

4.1 Drivers

4.2 Restrains

4.3 Opportunities

4.4 Challenges

4.5 Macroeconomic Indicators

4.6 Technology Trends & Assessment

5. Market Factor Analysis

5.1 Porter’s Five Forces Analysis

5.1.1 Bargaining Power of Suppliers

5.1.2 Bargaining Power of Buyers

5.1.3 Threat of New Entrants

5.1.4 Threat of Substitutes

5.1.5 Intensity of Rivalry

5.2 Value Chain Analysis

5.3 Investment Feasibility Analysis

5.4 Pricing Analysis

6. Global Microalbumin Test Market, by Product

6.1 Introduction

6.2 Analyzer

6.2.1 Market Estimates & Forecast, 2020-2027

6.3 Reagent Kit

6.3.1 Market Estimates & Forecast, 2020-2027

6.4 Control Kit

6.4.1 Market Estimates & Forecast, 2020-2027

6.5 Micro cuvettes

6.5.1 Market Estimates & Forecast, 2020-2027

6.6 Test Strips

6.6.1 Market Estimates & Forecast, 2020-2027

6.7 Others

6.7.1 Market Estimates & Forecast, 2020-2027

7. Global Microalbumin Test Market, by Indication

7.1 Introduction

7.2 Kidney Disease

7.2.1 Market Estimates & Forecast, 2020-2027

7.3 Diabetes

7.3.1 Market Estimates & Forecast, 2020-2027

7.4 High Blood Pressure

7.4.1 Market Estimates & Forecast, 2020-2027

7.5 Others

7.5.1 Market Estimates & Forecast, 2020-2027

8. Global Microalbumin Test Market, by End User

8.1 Introduction

8.2 Hospitals & Clinics

8.2.1 Market Estimates & Forecast, 2020-2027

8.3 Diagnostics Laboratories

8.3.1 Market Estimates & Forecast, 2020-2027

8.4 Research Laboratories

8.4.1 Market Estimates & Forecast, 2020-2027

8.5 Others

8.5.1 Market Estimates & Forecast, 2020-2027

9. Global Microalbumin Test Market, by Region

9.1 Introduction

9.2 Americas

9.2.1 North America

9.2.1.1 U.S.

9.2.1.2 Canada

9.2.2 South America

9.3 Europe

9.3.1 Western Europe

9.3.1.1 Germany

9.3.1.2 France

9.3.1.3 U.K

9.3.1.4 Italy

9.3.1.5 Spain

9.3.1.6 Rest of Western Europe

9.3.2 Eastern Europe

9.4 Asia Pacific

9.4.1 Japan

9.4.2 China

9.4.3 India

9.4.4 Australia

9.4.5 Republic of Korea

9.4.6 Rest of Asia Pacific

9.5 The Middle East & Africa

9.5.1 United Arab Emirates

9.5.2 Saudi Arabia

9.5.3 Oman

9.5.4 Kuwait

9.5.5 Qatar

9.5.6 Rest of the Middle East & Africa

10 Company Landscape

10.1 Introduction

10.2 Market Share Analysis

10.3 Key Development & Strategies

10.3.1 Key Developments

11 Company Profiles

11.1 Beckman Coulter

11.1.1 Company Overview

11.1.2 Product Overview

11.1.3 Financials

11.2 Abbott

11.2.1 Company Overview

11.2.2 Product Overview

11.2.3 Financial Overview

11.2.4 Key Developments

11.3 Nova Biomedical

11.3.1 Company Overview

11.3.2 Product Overview

11.3.3 Financial Overview

11.3.4 Key Development

11.4 Siemens

11.4.1 Company Overview

11.4.2 Product/Business Segment Overview

11.4.3 Financial Overview

11.4.4 Key Development

11.5 ARKRAY

11.5.1 Company Overview

11.5.2 Product Overview

11.5.3 Financial overview

11.5.4 Key Developments

11.6 ACON Laboratories

11.6.1 Company Overview

11.6.2 Product Overview

11.6.3 Financial Overview

11.6.4 Key Developments

11.7 Sysmex

11.7.1 Overview

11.7.2 Product Overview

11.7.3 Financials

11.7.4 Key Developments

11.8 Others

12 MRFR Conclusion

12.1 Key Findings

12.1.1 From CEO’s View Point

12.1.2 Unmet Needs of the Market

12.2 Key Companies to Watch

12.3 Prediction of Industry

13 Appendix

LIST OF TABLES

Table 1 Microalbumin Test Industry Synopsis, 2020-2027

Table 2 Global Microalbumin Test Market Estimates and Forecast, 2020-2027, (USD Million)

Table 3 Global Microalbumin Test Market by Region, 2020-2027, (USD Million)

Table 4 Global Microalbumin Test Market by Product, 2020-2027, (USD Million)

Table 5 Global Microalbumin Test Market by Indication, 2020-2027, (USD Million)

Table 6 Global Microalbumin Test Market by End Users, 2020-2027, (USD Million)

Table 7 North America Microalbumin Test Market by Product, 2020-2027, (USD Million)

Table 8 North America Microalbumin Test Market by Indication, 2020-2027, (USD Million)

Table 9 North America Microalbumin Test Market by End Users, 2020-2027, (USD Million)

Table 10 U.S. Microalbumin Test Market by Product, 2020-2027, (USD Million)

Table 11 US Microalbumin Test Market by Indication, 2020-2027, (USD Million)

Table 12 US Microalbumin Test Market by End Users, 2020-2027, (USD Million)

Table 13 Canada Microalbumin Test Market by Product, 2020-2027, (USD Million)

Table 14 Canada Microalbumin Test Market by Indication, 2020-2027, (USD Million)

Table 15 Canada Microalbumin Test Market by End Users, 2020-2027, (USD Million)

Table 16 South America Microalbumin Test Market by Product, 2020-2027, (USD Million)

Table 17 South America Microalbumin Test Market by Indication, 2020-2027, (USD Million)

Table 18 South America Microalbumin Test Market by End Users, 2020-2027, (USD Million)

Table 19 Europe Microalbumin Test Market by Product, 2020-2027, (USD Million)

Table 20 Europe Microalbumin Test Market by Indication, 2020-2027, (USD Million)

Table 21 Europe Microalbumin Test Market by End Users, 2020-2027, (USD Million)

Table 22 Western Europe Microalbumin Test Market by Product, 2020-2027, (USD Million)

Table 23 Western Europe Microalbumin Test Market by Indication, 2020-2027, (USD Million)

Table 24 Western Europe Microalbumin Test Market by End Users, 2020-2027, (USD Million)

Table 25 Eastern Europe Microalbumin Test Market by Product, 2020-2027, (USD Million)

Table 26 Eastern Europe Microalbumin Test Market by Indication, 2020-2027, (USD Million)

Table 27 Eastern Europe Microalbumin Test Market by End Users, 2020-2027, (USD Million)

Table 28 Asia Pacific Microalbumin Test Market by Product, 2020-2027, (USD Million)

Table 29 Asia Pacific Microalbumin Test Market by Indication, 2020-2027, (USD Million)

Table 30 Asia Pacific Microalbumin Test Market by End Users, 2020-2027, (USD Million)

Table 31 Middle East & Africa Microalbumin Test Market by Product, 2020-2027, (USD Million)

Table 32 Middle East & Africa Microalbumin Test Market by Indication, 2020-2027, (USD Million)

Table 33 Middle East & Africa Microalbumin Test Market by End Users, 2020-2027, (USD Million)

LIST OF FIGURES

Figure 1 Research Process

Figure 2 Segmentation for Global Microalbumin Test Market

Figure 3 Segmentation Market Dynamics for Microalbumin Test Market

Figure 4 Global Microalbumin Test Market Share, by Product 2020

Figure 5 Global Microalbumin Test Market Share, by Indication 2020

Figure 6 Global Microalbumin Test Market Share, by End Users, 2020

Figure 7 Global Microalbumin Test Market Share, by Region, 2020

Figure 8 North America Microalbumin Test Market Share, by Country, 2020

Figure 9 Europe Microalbumin Test Market Share, by Country, 2020

Figure 10 Asia Pacific Microalbumin Test Market Share, by Country, 2020

Figure 11 Middle East & Africa Microalbumin Test Market Share, by Country, 2020

Figure 12 Global Microalbumin Test Market: Company Share Analysis, 2020 (%)

Figure 13 Beckman Coulter: Key Financials

Figure 14 Beckman Coulter: Segmental Revenue

Figure 16 Beckman Coulter: Geographical Revenue

Figure 17 Abbott: Key Financials

Figure 18 Abbott: Segmental Revenue

Figure 19 Abbott: Geographical Revenue

Figure 20 GlaxoSmithKline plc: Key Financials

Figure 21 GlaxoSmithKline plc: Segmental Revenue

Figure 22 GlaxoSmithKline plc: Geographical Revenue

Figure 23 ARKRAY: Key Financials

Figure 24 ARKRAY: Segmental Revenue

Figure 25 ARKRAY: Geographical Revenue

Figure 26 ARKRAY: Key Financials

Figure 27 Sysmex: Segmental Revenue

Figure 28 Sysmex: Geographical Revenue

Figure 29 Sysmex: Key Financials

Figure 30 ACON Laboratories: Segmental Revenue

Figure 31 ACON Laboratories: Geographical Revenue

Figure 32 ACON Laboratories: Key Financials